MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Omega-3 formula put to the test for heart health
Disease control Not yet recruitingThis study aims to see if a new type of omega-3 supplement works better than a standard one for adults with mixed cholesterol problems. About 105 participants already taking stable cholesterol medication will take one of the supplements daily for 24 weeks. The main goal is to mea…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: NA • Sponsor: Fundación del Caribe para la Investigación Biomédica • Aim: Disease control
Last updated Apr 02, 2026 05:12 UTC
-
Three-Drug combo aims to shrink dangerous heart plaque before it causes a crisis
Disease control Not yet recruitingThis study aims to see if a combination of three cholesterol-lowering drugs can shrink and stabilize fatty plaque buildup in the heart's arteries. It will enroll about 103 adults who have this plaque but have not yet had a heart attack or stroke. Researchers will use special hear…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Doctors track cholesterol drugs in everyday patients
Disease control Not yet recruitingThis study aims to understand the real-world benefits and side effects of two cholesterol-lowering drugs, bempedoic acid and a combination pill with ezetimibe. It will observe about 2,560 adult patients with high cholesterol in Asia and Latin America during their regular doctor v…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists test how body handles new cholesterol pill
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how the body processes and tolerates two versions of a new drug candidate, AD-117, designed for mixed cholesterol problems. It will involve 60 healthy adult volunteers who will take single doses of the drug under fed conditions. The main …
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Addpharma Inc. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC